MUSCLE INVASIVE BLADDER CANCER

This study is testing whether a drug called atezolizumab can help prevent cancer from returning in people with high-risk bladder cancer who have had their bladder surgically removed. The trial will involve about 761 participants who have a specific blood marker suggesting a high …

This study is testing the safety and initial effectiveness of several new drug combinations for people with advanced bladder cancer that has continued to grow despite prior treatment. It enrolled 117 participants and assigns them to one of seven different treatment groups based o…

This large, global study is testing whether adding a newer immunotherapy drug (durvalumab) to standard chemotherapy before bladder removal surgery, and then continuing the immunotherapy alone after surgery, can better control cancer and prevent it from returning. It involves over…

This global study is testing whether adding new immunotherapy and targeted drugs to the treatment plan around bladder removal surgery works better than current standard care. It's for patients with muscle-invasive bladder cancer who are not eligible for or refuse the usual cispla…

This large, late-stage study is testing whether adding immunotherapy drugs (nivolumab with or without BMS-986205) to standard chemotherapy before bladder removal surgery, and continuing them afterward, works better than chemotherapy alone. It involves 855 adults with muscle-invas…